These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8578803)

  • 21. Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.
    Murphy CG; Lucas WT; Means RE; Czajak S; Hale CL; Lifson JD; Kaur A; Johnson RP; Knipe DM; Desrosiers RC
    J Virol; 2000 Sep; 74(17):7745-54. PubMed ID: 10933680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
    Meyer D; Anderson DE; Gardner MB; Torres JV
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins.
    Hulskotte EG; Dings ME; Norley SG; Osterhaus AD
    Vaccine; 1997 Dec; 15(17-18):1839-45. PubMed ID: 9413091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity.
    Tang S; van Rij R; Silvera D; Andino R
    J Virol; 1997 Oct; 71(10):7841-50. PubMed ID: 9311872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.
    Hel Z; Johnson JM; Tryniszewska E; Tsai WP; Harrod R; Fullen J; Tartaglia J; Franchini G
    Vaccine; 2002 Aug; 20(25-26):3171-86. PubMed ID: 12163269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
    Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
    Heeney JL; de Vries P; Dubbes R; Koornstra W; Niphuis H; ten Haaft P; Boes J; Dings ME; Morein B; Osterhaus AD
    J Med Primatol; 1992; 21(2-3):126-30. PubMed ID: 1433263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection.
    Lewis MG; Elkins WR; McCutchan FE; Benveniste RE; Lai CY; Montefiori DC; Burke DS; Eddy GA; Shafferman A
    Vaccine; 1993 Oct; 11(13):1347-55. PubMed ID: 7507625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of immunization on chemokines and CCR5 and CXCR4 coreceptor functions in SIV binding and chemotaxis.
    Wang Y; Tao L; Mitchell E; Bergmeier L; Doyle C; Lehner T
    Vaccine; 1999 Apr; 17(15-16):1826-36. PubMed ID: 10217580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques.
    Bergmeier LA; Mitchell EA; Hall G; Cranage MP; Cook N; Dennis M; Lehner T
    AIDS; 1998 Jul; 12(10):1139-47. PubMed ID: 9677162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
    Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen.
    Hanke T; Szawlowski P; Randall RE
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():653-60. PubMed ID: 1372038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences between T cell epitopes recognized after immunization and after infection.
    Vogel TU; Horton H; Fuller DH; Carter DK; Vielhuber K; O'Connor DH; Shipley T; Fuller J; Sutter G; Erfle V; Wilson N; Picker LJ; Watkins DI
    J Immunol; 2002 Oct; 169(8):4511-21. PubMed ID: 12370388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine.
    Robinson JE; Cole KS; Elliott DH; Lam H; Amedee AM; Means R; Desrosiers RC; Clements J; Montelaro RC; Murphey-Corb M
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1253-62. PubMed ID: 9764909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.
    Pinczewski J; Zhao J; Malkevitch N; Patterson LJ; Aldrich K; Alvord WG; Robert-Guroff M
    Viral Immunol; 2005; 18(1):236-43. PubMed ID: 15802969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques.
    Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M
    J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.
    Hu SL; Travis BM; Stallard V; Abrams K; Misher L; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1489-94. PubMed ID: 1466988
    [No Abstract]   [Full Text] [Related]  

  • 40. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.
    Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.